Lung Cancer Symptom Assessment and Management Intervention

Completed · Phase 2

Conditions studied: Lung Cancer

In brief

The purpose of this study is to develop and test the usability of a computerized symptom assessment and management intervention system in a laboratory setting (phase I) and its feasibility in a clinical setting in a group randomized trial (phase II).

Key facts

Study ID

NCT00852462

Run by

Dana-Farber Cancer Institute

People needed

179

Starts

2008-05-01

Expected to finish

2016-06-01

Last updated by the study team

2016-10-21

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HCPs: attending physician, thoracic medical oncologist, expected to work in the setting for at least 2 years.
• Patients: 21 years of age or older; diagnosis of Stage IIIA, IIIB, IV non-small cell lung cancer OR limited or extensive stage small cell lung cancer; receiving care in the out-patient setting; receiving treatment with chemotherapy +/- additional therapies; English speaking.

You may not qualify if…

• Patients: Any patient who needs emergent care, routine visits scheduled less than once a month

Where it is running

• Dana-Farber Cancer Institute — Boston, Massachusetts, United States
• Boston Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.